https://doi.org/10.1007/s00392-025-02625-4
1Universitätsklinikum Leipzig Klinik und Poliklinik für Kardiologie Leipzig, Deutschland; 2Universitätsklinikum Leipzig Klinik und Poliklinik für Endokrinologie, Nephrologie, Rheumatologie Leipzig, Deutschland
We characterized 12 LMNA mutations identified in a FPLD2 patient cohort using DNA sequencing to analyze the effects on EC identity and integrity to identify potential pathological variants for the cardiovascular system.
All 12 identified FPLD2-associated LMNA mutations were introduced into the wild-type LMNA gene by site-directed mutagenesis and subsequently used to synthesize modified mRNAs for each variant. Transfer of the LMNA mRNA variants into human ECs resulted in a significant increase of LMNA levels. Interestingly, although overexpressed at the mRNA level, transfection of three mutations (c.1445G>A, c.1699-2A>G and c.1930C>T) resulted in reduced lamin A/C protein levels. Overexpression of the c.1444C>T LMNA variant induced EndMT and EC senescence as determined by increased mRNA levels of the mesenchymal marker CNN1 and the senescence-associated genes p16, p21, GDF15 and IL6. Immunofluorescence revealed increased nuclear abnormalities, such as increased nuclear invaginations, which are associated with cellular senescence, after overexpression of LMNA mutant variants (c.1304G>A, c.1444C>T and c.1445G>A). This was further enhanced when ECs were stressed by additional induction of EndMT, resulting in significantly increased nuclear abnormalities for LMNA mutations (c.1411C>G, c.1445G>A, c.1445G>C and c.1634G>A). Single-cell Multiome sequencing of EC overexpressing the LMNA c.1445G>A variant revealed lower RNA expression of EndMT-associated genes such as MGP1 or TIMP1, as well as the inflammatory marker CCL14, compared to LMNA wild-type transfected EC.
Taken together, these results indicate that LMNA mutations affect endothelial identity and survival potentially by interfering with nuclear integrity.